NA Proactive news snapshot: Empower Clinics, Marrone Bio, Phunware, Fidelity Minerals UPDATE…

Empower Clinics Inc (OTCMKTS:EPWCF) (CSE:CBDT) (FRA:8EC) announced Monday that it has closed on an upsized private placement that raised more than C$1.2 million. In a statement, the company said it intends to use the net proceeds to support clinic growth, lab testing services, sales and marketing, and general working capital purposes. The company issued 24,567,131 units at C$0.05 per each consisting of one share and one purchase warrant. Each warrant can acquire one share at C$0.12 per apiece for a period of 24 months from the closing.Empower also said that CEO Steven McAuley participated in the offering by subscribing for 1,200,000 units for $60,000. Marrone Bio Innovations Inc (NASDAQ:MBII) reported third-quarter revenue Monday that grew 27% year-over-year to $8.8 million thanks in part to the company’s strategic expansion in international and seed treatment markets. In the US, Marrone’s biological seed treatments for corn and soybeans are entering their third year on the market and delivered a sales increase in the three months ended September 30. Elsewhere, sales also benefited from the introduction in Latin America of a new foliar treatment to promote plant health for soybeans. That helped lead to an adjusted net loss that narrowed 63% to $6.1 million from $16.4 million in the same period a year earlier. Gross profit, meanwhile, increased 40% to $5 million from $3.6 million. Phunware Inc (NASDAQ:PHUN) saw its quarter-over-quarter revenue rise by 40% to $3.1 million during its third quarter, according to its financial results reported Monday. Net revenue for the three-month period ended September 30, 2020 totaled $3.13 million, with its Multiscreen-as-a-Service (MaaS) platform subscriptions and services accounting for $2.86 million. The enterprise cloud platform company also posted health gross margins of just over 71% during the quarter as it worked to reduce its cash burn and improve its cash position, which resulted in a 30% decrease in adjusted EBITDA loss of $1.3 million. Fidelity Minerals Corp (CVE:FMN) announced Monday an update on surface sampling progress at its 100% owned Las Brujas gold project in Peru. The company initiated geological mapping and sampling projects on September 9, 2020, within the Las Brujas Gold 2 Concession. To date 273 results have been received, with 12 notably contiguous two metres channel samples collected across an iron oxide-rich tectonic breccia returned a weighted average 0.22 grams per tonne (g/t) gold over 24 metres. This mineralization is also characterized by copper concentrations that vary from 72 to 158 ppm copper. Biocept Inc (NASDAQ:BIOC), a leading commercial provider of molecular diagnostic assays, announced that it has been awarded a patent in Hong Kong for the enhanced detection of rare cells, including cancer cells. In a statement, the San Diego-based molecular diagnostics company said Hong Kong Patent No. 1188285, entitled “Methods and Reagents for Signal Amplification,” covers methods for enhancing the detection of cells using fluorescent complexes, including for circulating tumor cells (CTCs).  Blackrock Gold Corp (CVE:BRC) (OTCQB:BKRRF) (FRA:AHZ) Monday reported that it has started drilling its flagship Silver Cloud project, a 4500-plus hectare property in Nevada, on the convergence of the Carlin Trend and Northern Nevada Rift. The company said it will drill up to 3,500 metres in 14 reverse circulation (RC) drill holes across four distinct target areas, with most of the drilling focused on the newly-delineated, yet untested, NE Veins target.  Global Energy Metals Corporation (CVE:GEMC) (OTCMKTS:GBLEF) (FRA:5GE2) told investors that the reinterpretation of data by recently hired SJ Geophysics Ltd for its Lovelock mine and Treasure Box battery metals projects in Nevada, US will be instrumental in defining targets for a potential drill program. As reported last month, the consultant was hired to review previous airborne magnetic data and assemble a detailed, interpretation program including a 3D model for the project. "The company believes that the SJ Study, extending from previously mined orebodies to key undeveloped prospects and exploration targets, greatly enhances the company's ability to successfully target and explore for new, buried, high-grade cobalt-nickel-copper deposits across the large footprint in a highly prospective mining district," said Mitchell Smith, Global Energy Metal's chief executive in a statement. Ipsidy Inc (OTCQB:IDTY) CEO Phillip Kumnick said Monday that the company which is a dominant player in the crucial multi-factor authentication and identity management space saw "continued progress" in the third quarter and was "successful in securing new customers in the financial services sector." “The last quarter has seen continued progress for Ipsidy,” Kumnick said in a statement accompany in the company's latest numbers.  Falcon Gold Corp (CVE:FG) (OTCPINK:FGLDF) reported Monday that it has mobilized the diamond drill and crews for its 2020 Stage Two drilling program at the Central Canada Gold mine near Atikokan, northwestern Ontario. Since concluding the first-round summer drill program comprising seven holes and totaling 1,055 meters (m) of core at the Central Canada gold mine, the company said it has evaluated the new geological and analytical data achieved by the drilling. The gold-mineralized mine zone strikes east-north-east and extends well beyond the area drilled by Falcon. The width of the zone is also quite noteworthy, as seen in Falcon's hole CC 20-01. The structure occupies more than 60m of core length and contains a number of mineralized intervals. The company said the gold mineralization in CC20-01 commenced at 67m with an interval of 10.2 grams per ton (g/t) Au over 3m within the broader zone of 1.2 g/t Au over 19m. The drill also intersected an additional high-grade quartz vein at 104m, which sampled 18.6 g/t Au over 1m. Algernon Pharmaceuticals Inc (CSE:AGN) (OTCQB:AGNPF) said that it plans to conduct an interim data review of its multinational Phase 2b/3 human trial of its lead drug NP-120 (Ifenprodil) as a potential treatment for coronavirus (COVID-19) sufferers. In a statement, Vancouver clinical-stage pharmaceutical company said it will look at the primary endpoint of the World Health Organization (WHO) ordinal score and also secondary endpoints including the number of days that patients were in the ICU and the hospital, as well as the number of days patients were on mechanical ventilation. The data, from 75 patients on day 15 of the study, will be presented in a descriptive statistics format and Algernon is projecting the data readout will be in the first week of December. Fury Gold Mines Limited (TSE:FURY) (NYSEAMERICAN:FURY) (FRA:AUN1) Monday announced that it has commenced drilling at its Eau Claire project in the James Bay region of Quebec. The company will conduct 50,000 metres of drilling, consisting of 25,000 metres of infill drilling on the southeast margin of the existing Inferred resource (currently defined by 200,000 ounces at 12.2 grams per tonne gold) and includes about 10,000 metres to 12,000 metres (m) of exploration drilling, which will test a one-kilometre down plunge extension of the Eau Claire deposit with the goal of significantly expanding the deposit footprint.  Zynerba Pharmaceuticals Inc (NASDAQ:ZYNE) (FRA:6ZY) has posted third-quarter results with ample cash on hand, which gives the company a long runway to further develop its flagship product Zygel (ZYN002), a patent-protected CBD skin gel, which is being developed to treat a slew of rare neuropsychiatric disorders, including Fragile X syndrome (FXS) and developmental and epileptic encephalopathies (DEE) programs. The Devon, Pennsylvania-based company had $64.3 million in cash and equivalents as of September 30, 2020, compared to $70.1 million at the end of December 2019. For the period ended September 30, 2020, the company reported R&D expenses of $5.8 million, including stock-based compensation of $0.5 million. Benchmark Metals Inc (CVE:BNCH) (OTCQX:BNCHF) continues to expand the Cliff Creek zone at its flagship Lawyers gold and silver project in British Columbia with drilling, which augurs well for a new resource estimate earmarked for the first quarter of 2021. The firm has now defined mineralization from surface over a 1.2 kilometre (km) strike at Cliff Creek, with a width of up to 200 metres and a depth of over 500 metres. Latest drill assays from the southern extent of the zone returned broad zones of mineralization, including 128.10 metres (m) of 1.65 grams per tonne (g/t) gold and 110.02 g/t silver. Nextleaf Solutions Ltd (CSE:OILS) (OTCQB:OILFF) (FRA:L0MA) announced Monday that subsidiary Nextleaf Labs Ltd has entered into a cannabis extraction agreement with Natural MedCo Ltd (NMC). NMC, a wholly-owned subsidiary of Eve & Co Incorporated (CVE:EVE) (OTCQX:EEVVF), is based in Strathroy, Ontario and operates over 1 million square feet of licensed production and distribution through provincial adult-use channels and international markets.  GlobeX Data Ltd (CSE:SWIS) (OTCQB:SWISF) has signed a distribution agreement in Kuwait for its Sekur and SekurSafe data solutions, it announced Monday. The agreement with IT distribution firm Digital Processing System, Kuwait (DPS KW) brings Toronto- and New York-based GlobeX’s secure communications platforms to the Middle Eastern country. Meanwhile, the firm also told shareholders that it has kick-started a drive to sign more agreements in the Gulf Cooperation Council countries, including Bahrain, Oman, Saudi Arabia and the UAE.  DPS KW has started introducing GlobeX to potential clients and distributing all of its solutions, according to the company. Karora Resources Inc (TSE:KRR) (OTCMKTS:KRRGF) (FRA:5RN1) updated investors Monday on its mining strategy going forward, which includes an ongoing analysis to outline a potential economic starter pit at its Aquarius project in Australia and plans to optimize the mill at its Higginsville plant. The search for a started pit at Aquarius follows a near-surface drill program that identified 43.5 grams per ton (g/t) gold over 3 meters (m) and 5.7 g/t over 6m.  A total of 54 holes, totaling 5,079m have been completed. O3 Mining Inc (CVE:OIII) (OTCMKTS:OQMGF) said it has consolidated its ground at the Malartic property in Quebec after completing its purchase of the remaining 50% of so-called Northern Star claims. The explorer paid US$150,000 for the acquisition, following the terms between Niogold Mining Corp (which is owned by O3 Mining) and 9265-991 Québec Inc, which bought the mining interests of Northern Star Mining Corp in 2013. Hillcrest Petroleum Ltd (CVE:HRH) (OTCMKTS:HLRTF) (FRA:7HI) announced Monday that clean-energy expert Ari Berger has been appointed to Hillcrest's executive team as General Manager Technology Development. Having previously acted in an advisory capacity, Berger will now assume the role of Hillcrest's in-house chief technology consultant, responsible for building, developing, and overseeing its clean energy technology initiatives. Hillcrest said Berger is an expert in electric motor control technologies with specific expertise in system engineering. His latest position was Chief Technology Officer at Exro Technologies Inc (CVE:EXRO) (OTCQB:EXROF) (FRA:1O2). Mineworx Technologies Ltd (CVE:MWX) (OTCQB:MWXRF) (FRA:YRS) announced Monday that the engineering and design phase of its pilot plant is near completion, and the procurement of equipment and related components has begun.  In a statement, the company said the announcement marks the next step in refining the process to maximize the recovery of platinum group metals (PGM) from diesel catalytic converters. The assembly of the plant along with initial testing will be at the Mineworx facility in the Vancouver, British Columbia area. Upon completion of this initial testing phase, the plant will be moved to Tennessee for further testing in a commercial production environment with its partner Davis Recycling Ltd. Pacific Empire Minerals Corp. (CVE:PEMC) has announced the appointment of George Cavey as a Qualified Person within the meaning of National Instrument 43-101 - Standards of Disclosure for Mineral Projects. The Company also announces the resignation of Rory Ritchie as Pacific Empire's vice president of Exploration and Director, effective immediately. Brad Peters, Pacific Empire's president and chief executive pfficer commented: "Rory has been a key contributor to Pacific Empire since its inception in 2012 and has been instrumental in the acquisition and maintenance of our current portfolio of prospective mineral projects, our successful initial public offering on the TSX Venture Exchange in 2018 and our first few years as a public company. We are grateful to have Rory continue as one of our major shareholders. I would like to express my sincere gratitude to Rory for his significant contributions to Pacific Empire's development and wish him continued success in his new position." Metalla Royalty & Streaming Ltd. (NYSEAMERICAN:MTA) (CVE:MTA) has announced that at its annual general meeting of shareholders, held on November 4, 2020, a total of 17,014,694 shares were represented at the meeting, being 44.90% of the company's issued and outstanding common shares, and shareholders approved all of the matters brought before the meeting. The company also said it has granted options to certain officers, directors, and employees to purchase an aggregate of 420,000 common shares under its share compensation plan, with an exercise price of C$12.85 per common share. Each option grant vests in four equal installments every six months from the date of issue. Each option is exercisable, once vested, for a period of 5 years from the date of the grant. Ximen Mining Corp (CVE:XIM) said the TSX Venture Exchange has accepted for filing documentation with respect to its non-brokered private placement announced on November 6, 2020, that sees the issue of 1.6 million shares at a purchase price of 25.5 cents each, together with 1.6 million share purchase warrants with an exercise price of 35 cents for a two-year period, with four placees. 1933 Industries Inc. (CSE:TGIF) (OTCQX:TGIFF), a vertically-integrated cannabis consumer packaged goods company with a diverse portfolio of consumer-driven brands, has announced the incentive grant of 12,050,000 stock options to its directors, officers, consultants and employees under the company's stock option plan. The options are exercisable for a period of five years at a price of $0.10 per share and will vest over a three-year period. Bragg Gaming Group Inc. (CVE:BRAG) (OTCMKTS:BRGGF) has said it intends to hold its upcoming annual and special meeting of shareholders on November 27, 2020, at 10:00 a.m. (Toronto time). In light of the impacts associated with the coronavirus (COVID-19) pandemic, and subject to restrictions related to group gatherings at the time of the meeting, the company plans to conduct it both in-person and through remote communication. The company is encouraging shareholders and others not to attend the meeting in person. The company is offering shareholders the option to listen and participate (but not vote) at the seeting in real-time by conference call at the following coordinates: 1-800-901-0218 (North America Toll Free) or 1-719-234-0223 (outside of North America); Guest Passcode: 320 351 4218#. The company also announced that, further to its news release of September 30, 2020, the second and final earn-out payment of €22 million (approximately C$34,289,200) owing to K.A.V.O. Holdings Limited, as Oryrx vendor, will be converted into common shares of the company by January 31, 2021, at a deemed conversion price of C$0.73, being 47,000,000 common shares. The satisfaction of the second and final earn-out payment is subject to certain conditions, including receiving disinterested shareholder approval for the creation of the vendor as a "control person" of the company, being a holder of greater than 20% of the voting rights of the company's outstanding securities. The company intends to seek disinterested shareholder approval for the creation of Oryx vendor as a "control person" at the upcoming meeting. Medexus Pharmaceuticals Inc. (CVE:MDP) (OTCQX:MEDXF) (FRA:P731) hasv announced that it plans to host a conference call at 8.00am Eastern Time on Tuesday, November 17, 2020, to discuss the company’s financial results for the fiscal 2021 second quarter ended September 30, 2020, as well as the company’s corporate progress and other developments. The company expects to file its financial statements along with its MD&A post-market on November 16, 2020. The conference call will be available via telephone by dialing toll-free 844-369-8770 for Canadian and US callers or +1 862-298-0840 for international callers, or on the company’s Investor Events section of the website: https://www.medexus.com/en_US/investors/news-events. A webcast replay will be available on the company’s Investor Events section of the website (https://www.medexus.com/en_US/investors/news-events) through Wednesday, February 17, 2021. A telephone replay of the call will be available approximately one hour following the call, through Tuesday, November 24, 2020 and can be accessed by dialing 877-481-4010 for Canadian and US callers or +1 919-882-2331 for international callers and entering conference ID: 38655. VolitionRx Limited (NYSEAMERICAN:VNRX)has announced that it will host a conference call on Friday, November 13, at 8.30am Eastern Time to discuss its financial and operating results for the third quarter 2020, in addition to providing a business update.  Cameron Reynolds, president and chief executive officer of Volition, will host the call along with David Vanston, chief financial officer and Scott Powell, executive vice president, Investor Relations. The call will provide an update on recent developments and Volition's activities, including details of new and ongoing clinical trials, important events which have taken place in the third quarter of 2020, and milestones for the remainder of 2020 and beyond. Conference call dial-in details: US & Canada Dial-in: 1-877-407-9716 (toll free); UK Dial-in: 0 800 756 3429 (toll free); Toll/International: 1-201-493-6779; Conference ID:  13713126. A live audio webcast of the conference call will also be available on the investor relations page of Volition's corporate website at http://ir.volition.com. In addition, a telephone replay of the call will be available until November 27, 2020. The replay dial-in numbers are 1-844-512-2921 (toll-free) in the US and Canada and 1-412-317-6671 (toll) internationally. Please use replay pin number 13713126. OTC Markets Group Inc. (OTCQX:OTCM), operator of financial markets for over 11,000 U.S. and global securities, has announced that Minera Alamos, Inc. (CVE:MAI) (OTCQX:MAIFF), a gold development company, has qualified to trade on the OTCQX Best Market and has today upgraded from the OTCQB Venture Market. Graduating to the OTCQX Market from the OTCQB Market marks an important milestone for companies, enabling them to demonstrate their qualifications and build visibility among U.S. investors. "We are delighted to have qualified to trade on the OTCQX Market, which is indicative of just how far Minera has come over the last 2 years." Stated Doug Ramshaw, Minera Alamos president. "As we transition from a gold development company to gold producer in early 2021 we believe the heightened visibility that comes with meeting the standards of the OTCQX will serve our Company and shareholders well over the coming years." Tonix Pharmaceuticals Holding Corp (NASDAQ:TNXP) CEO Seth Lederman will be speaking at the third annual Neuropsychiatric Drug Development Summit being held virtually November 10-12, 2020. Lederman’s presentation is titled “Developing a PTSD Therapeutic - Phase 3 Clinical Development.” The talk is scheduled to begin at 11:55am ET on November 12.